48,136 Shares in STERIS plc (NYSE:STE) Bought by Proficio Capital Partners LLC

Proficio Capital Partners LLC purchased a new position in STERIS plc (NYSE:STE - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 48,136 shares of the medical equipment provider's stock, valued at approximately $9,895,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of STE. Geode Capital Management LLC lifted its position in shares of STERIS by 0.7% during the third quarter. Geode Capital Management LLC now owns 2,303,625 shares of the medical equipment provider's stock worth $556,786,000 after purchasing an additional 17,007 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in STERIS by 0.5% during the 4th quarter. Principal Financial Group Inc. now owns 1,119,643 shares of the medical equipment provider's stock valued at $230,160,000 after buying an additional 5,419 shares in the last quarter. Franklin Resources Inc. boosted its position in STERIS by 171.2% in the 3rd quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider's stock valued at $191,370,000 after buying an additional 529,308 shares during the period. Charles Schwab Investment Management Inc. grew its stake in STERIS by 3.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 569,837 shares of the medical equipment provider's stock worth $117,136,000 after acquiring an additional 18,384 shares in the last quarter. Finally, Swiss National Bank increased its position in shares of STERIS by 0.3% during the third quarter. Swiss National Bank now owns 293,360 shares of the medical equipment provider's stock worth $71,152,000 after acquiring an additional 800 shares during the period. 94.69% of the stock is owned by institutional investors.

Remove Ads

STERIS Stock Down 1.3 %

Shares of NYSE STE traded down $2.89 during mid-day trading on Wednesday, reaching $225.44. 268,489 shares of the company were exchanged, compared to its average volume of 516,493. The firm has a 50-day moving average of $220.09 and a 200 day moving average of $222.22. STERIS plc has a 1 year low of $197.82 and a 1 year high of $248.24. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The stock has a market cap of $22.15 billion, a price-to-earnings ratio of 47.86 and a beta of 0.92.

STERIS (NYSE:STE - Get Free Report) last announced its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, research analysts expect that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be issued a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.01%. The ex-dividend date is Thursday, February 20th. STERIS's dividend payout ratio (DPR) is presently 48.41%.

Analyst Ratings Changes

A number of brokerages recently issued reports on STE. JMP Securities reiterated a "market outperform" rating and issued a $265.00 price target on shares of STERIS in a report on Thursday, February 6th. Stephens reissued an "overweight" rating and set a $240.00 price target on shares of STERIS in a research report on Thursday, February 6th. Finally, Piper Sandler raised their price target on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, STERIS has an average rating of "Moderate Buy" and an average target price of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.